Default company panoramic image

Boulder Diagnostics

Boulder Diagnostics develops and markets cutting edge in vitro diagnostics for difficult to diagnose diseases such as Lyme and Q-fever.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Boulder, CO, USA
  • Currency USD
  • Founded July 2009
  • Employees 11
  • Website

Company Summary

Boulder Diagnostics Inc. is dedicated to bringing new diagnostic tests to market for diseases that are not reliably diagnosed today. We work with leading academic institutions and innovative companies to identify scientific breakthroughs that can deliver new, reliable diagnostic tests where today’s standard methods fail.


  • Default avatar
    Wolfgang Pieken
    Chief Executive Officer

    2009 - Present: CEO Boulder Diagnostics Inc
    2007 - Present: Partner Inveni Capital
    2003 - 2007: Partner Ventac Partners:
    - Management Consultant HAC Biomed
    2002 - 2005: CEO MWG Biotech AG
    1998 - 2002: CEO Proligo LLC
    1992 - 1998: NeXstar Pharmaceuticals
    1990 - 1992: Max-Planck Institute for Experimental Medicine
    1985 - 1989: Graduate School U Maryland

  • Default avatar
    Dede Willis
    Chief Operating Officer

    2009 - Present: COO Boulder Diagnostics
    2003- Present: Partner, Ventac Partners
    2004-2007: Vice President Operations, Colorado Altitude Training
    1999-2002: VP Operations Proligo LLC and Managing Director, Proligo Biochemie GmbH
    1998-1999 President & CEO, Herberts Refinishes Corp
    1997-1998 Director, Strategy Development, Herberts GmbH
    1984-1996: Hoechst Group
    1992: University of Houston, MBA
    1984: Clemson University, BS, Chemical Enginee